Pancreatic Cancer Research

ResearcherWenzhou Medical UniversityNo recent work listed

Weitian Wei

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9970-2381; OpenAlex author ID A5028503185. Sources: OpenAlex.

Their work

Papers
5 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2012: 2 papers · 2013: none · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper

Papers 5

  1. Emodin reverses resistance to gemcitabine in pancreatic cancer by suppressing stemness through regulation of the epithelial‑mesenchymal transition. Co-author DOI 10.3892/etm.2022.11706↗
  2. MiR-199 Reverses the Resistance to Gemcitabine in Pancreatic Cancer by Suppressing Stemness through Regulating the Epithelial-Mesenchymal Transition. Co-author DOI 10.1021/acsomega.1c02945↗
  3. Oridonin induces apoptosis in SW1990 pancreatic cancer cells via p53- and caspase-dependent induction of p38 MAPK. Co-author DOI 10.3892/or.2013.2888↗
  4. Antitumor activity of emodin against pancreatic cancer depends on its dual role: promotion of apoptosis and suppression of angiogenesis. First author DOI 10.1371/journal.pone.0042146↗
  5. Enhanced antitumor efficacy of gemcitabine by evodiamine on pancreatic cancer via regulating PI3K/Akt pathway. Co-author DOI 10.7150/ijbs.8.1↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jinshi Liu · 1 shared paper, 2023 · strength 0.24
  2. Lisong Teng · 1 shared paper, 2021 · strength 0.17
  3. Jinxiao Liang · 1 shared paper, 2021 · strength 0.17
  4. Liang Wang · 1 shared paper, 2021 · strength 0.17
  5. Dian-Lei Liu · 3 shared papers, 2012–2014 · strength 0.11
  6. Hongfei Tong · 2 shared papers, 2012 · strength 0.06
  7. Hongchun Guo · 2 shared papers, 2012 · strength 0.06
  8. Zhaohong Wang · 2 shared papers, 2012 · strength 0.06
  9. Heqi Bu · 1 shared paper, 2014 · strength 0.05
  10. Junhui Cui · 1 shared paper, 2014 · strength 0.05
  11. Hai Huang · 1 shared paper, 2014 · strength 0.05
  12. Shengzhang Lin · 1 shared paper, 2012 · strength 0.03
  13. Sheng‐Zhang Lin · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.